Bioceres Crop Solutions (NASDAQ:BIOX) Stock Rating Upgraded by Wall Street Zen

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.

Separately, Oppenheimer dropped their price objective on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a report on Tuesday, April 22nd. One analyst has rated the stock with a hold rating, four have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Bioceres Crop Solutions presently has a consensus rating of "Buy" and an average price target of $8.63.

Bioceres Crop Solutions Stock Performance

Shares of BIOX traded up $0.13 during midday trading on Friday, reaching $4.68. 178,515 shares of the stock were exchanged, compared to its average volume of 177,405. The company has a quick ratio of 0.96, a current ratio of 1.32 and a debt-to-equity ratio of 0.43. The stock's 50 day simple moving average is $4.56 and its 200 day simple moving average is $5.19. Bioceres Crop Solutions has a twelve month low of $3.51 and a twelve month high of $11.78. The company has a market cap of $293.48 million, a P/E ratio of -33.43 and a beta of 0.44.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative return on equity of 2.36%. The firm had revenue of $59.60 million for the quarter, compared to analyst estimates of $61.80 million. On average, sell-side analysts expect that Bioceres Crop Solutions will post -0.05 earnings per share for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Hedge funds and other institutional investors have recently modified their holdings of the business. JPMorgan Chase & Co. boosted its stake in Bioceres Crop Solutions by 17.0% in the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock valued at $640,000 after buying an additional 15,328 shares in the last quarter. Stifel Financial Corp lifted its holdings in shares of Bioceres Crop Solutions by 51.9% in the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock worth $377,000 after acquiring an additional 21,168 shares during the last quarter. Northern Trust Corp acquired a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at approximately $93,000. Ballast Asset Management LP boosted its stake in shares of Bioceres Crop Solutions by 23.5% in the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after purchasing an additional 82,187 shares in the last quarter. Finally, Fourth Sail Capital LP grew its holdings in shares of Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock valued at $22,490,000 after purchasing an additional 527,859 shares during the last quarter. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.